The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12

<p class='bwalignc'> <i><b>Webcast Available Through Gilead Corporate Website</b></i> </p>

Wednesday, September 05, 2012

Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 1216:30 EDT Wednesday, September 05, 2012 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Morgan Stanley Global Healthcare Conference in New York. John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the Morgan Stanley conference on Wednesday, September 12 at 12:05 p.m. Eastern Time. To access the live webcast or a replay via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com orcall the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Patrick O?Brien, 650-522-1936Investor Relations